睿昂基因(688217)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688217 睿昂基因

已收盘 12-19 15:00:00

{"stockData":{"symbol":"688217","market":"SH","secType":"STK","nameCN":"睿昂基因","latestPrice":23.18,"timestamp":1734591600000,"preClose":23.86,"halted":0,"volume":2608406,"delay":0,"floatShares":55855900,"shares":55855900,"eps":-0.0926,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.68,"latestTime":"12-19 15:00:00","open":23.64,"high":24.21,"low":22.44,"amount":60183500,"amplitude":0.0742,"askPrice":23.18,"askSize":23,"bidPrice":23.15,"bidSize":4,"shortable":0,"etf":0,"ttmEps":-0.0926,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734658200000},"adr":0,"adjPreClose":23.86,"symbolType":"stock_kcb","openAndCloseTimeList":[[1734571800000,1734579000000],[1734584400000,1734591600000]],"highLimit":26.25,"lowLimit":21.47,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":55855896,"pbRate":1.39,"roa":"--","roe":"0.61%","epsLYR":0.14,"committee":0.044776,"marketValue":1295000000,"floatMarketCap":1295000000,"peRate":-250.323966,"changeRate":-0.0285,"turnoverRate":0.0467,"status":1,"afterMarket":{"amount":0,"volume":0,"close":23.18,"buyVolume":200,"sellVolume":0,"time":1734593638975,"indexStatus":"已收盘 12-19 15:30:00","preClose":23.86}},"requestUrl":"/m/hq/s/688217","defaultTab":"news","newsList":[{"id":"2492095553","title":"睿昂基因12月17日获主力加仓1389万元 环比增加1174.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492095553","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492095553?lang=zh_cn&edition=full","pubTime":"2024-12-17 15:20","pubTimestamp":1734420052,"startTime":"0","endTime":"0","summary":"12月17日, 睿昂基因股价涨0.04%，报收23.43元，成交金额1.06亿元，换手率8.04%，振幅5.12%，量比1.70。睿昂基因今日主力资金净流入1389万元，连续3日净流入，上一交易日主力净流入109万元，今日环比增加1174.31%。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为46.15%，平均涨幅为3.75%。该股近5个交易日上涨12.64%，主力资金累计净流入1110万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入129万元，其中净流入天数为10日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217154408ab7e7ed5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217154408ab7e7ed5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688217","BK0239"],"gpt_icon":0},{"id":"2492678750","title":"睿昂基因（688217）12月16日主力资金净买入205.01万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492678750","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492678750?lang=zh_cn&edition=full","pubTime":"2024-12-17 08:10","pubTimestamp":1734394242,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年12月16日收盘，睿昂基因报收于23.42元，上涨12.6%，换手率12.11%，成交量6.76万手，成交额1.55亿元。近5日资金流向一览见下表：睿昂基因融资融券信息显示，融资方面，当日融资买入1593.82万元，融资偿还1392.83万元，融资净买入201.0万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121700007630.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688217"],"gpt_icon":0},{"id":"2491615412","title":"睿昂基因上涨 获融资净买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2491615412","media":"智选洞察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491615412?lang=zh_cn&edition=full","pubTime":"2024-12-16 09:31","pubTimestamp":1734312686,"startTime":"0","endTime":"0","summary":"12月16日，睿昂基因股价大幅上涨，截至09点31分，睿昂基因上涨5.10%，报21.86元/股，成交379万元，换手率0.32%，振幅4.42%。资金动向截止发稿，睿昂基因获得主力净流出61万元，其中超大单流出9万元，大单流出51万元。融资融券方面，睿昂基因12月13日获得融资净买入294万元，当日该股融资余额为6579万元，当较前一日增加4.68%。最新财报显示，今年三季报，睿昂基因实现营业收入1.90亿元，同比减少4.62%，净利润为572.73万元，同比减少69.58%，基本每股收益为0.10元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216093551984c5504&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216093551984c5504&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688217"],"gpt_icon":0},{"id":"2490873384","title":"睿昂基因实控人熊慧姐弟涉诈骗罪被捕 或卷入阿斯利康骗保案股价三年半跌84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490873384","media":"长江商报","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490873384?lang=zh_cn&edition=full","pubTime":"2024-12-12 10:55","pubTimestamp":1733972131,"startTime":"0","endTime":"0","summary":"此前，睿昂基因副总经理何俊彦、副总经理薛愉玮因涉嫌诈骗罪被刑事拘留。有消息称，睿昂基因熊慧等4人所涉嫌“诈骗罪”或与阿斯利康骗保案有关。10月26日，睿昂基因发布公告称，近日，公司收到以上四人家属通知，熊慧、熊钧、薛愉玮、何俊彦的强制措施变更为刑事拘留，涉嫌罪名变更为诈骗罪。截至2024年12月11日收盘，睿昂基因股价达21.28元/股，约三年半时间下跌约84%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212110717ab713eb3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212110717ab713eb3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","LU0889565916.HKD","BK4007","LU2417539215.USD","688217","LU2462157665.USD","LU0320765992.SGD","LU2236285917.USD","LU1829250122.USD","BK4568","AZN","LU0109394709.USD","LU2456880835.USD","BK4588"],"gpt_icon":0},{"id":"2490861065","title":"实控人被批捕、第三季度亏损 睿昂基因如何“破局”？","url":"https://stock-news.laohu8.com/highlight/detail?id=2490861065","media":"新京报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490861065?lang=zh_cn&edition=full","pubTime":"2024-12-11 17:55","pubTimestamp":1733910958,"startTime":"0","endTime":"0","summary":"睿昂基因近日发布公告，公司实控人、董事长兼总经理熊慧，实控人、董事兼副总经理熊钧因涉嫌诈骗罪已被批捕，并移交检察机关。今年第三季度亏损在此次核心高管被曝出事前，睿昂基因也算得上检测行业的“明星企业”，并一度受益于新冠病毒检测业务。今年上半年，睿昂基因白血病分子检测相关产品贡献收入7867.03万元，同比上升7.67%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211175943a1e5d726&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211175943a1e5d726&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688217"],"gpt_icon":0},{"id":"2490061335","title":"睿昂基因：实际控制人熊慧、熊钧被批捕","url":"https://stock-news.laohu8.com/highlight/detail?id=2490061335","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490061335?lang=zh_cn&edition=full","pubTime":"2024-12-10 16:52","pubTimestamp":1733820732,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["688217","BK0239"],"gpt_icon":0},{"id":"2489929272","title":"IPO企业上市刚满3年！实控人姐弟因涉嫌诈骗罪，双双被批捕！","url":"https://stock-news.laohu8.com/highlight/detail?id=2489929272","media":"企业上市","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489929272?lang=zh_cn&edition=full","pubTime":"2024-12-08 06:52","pubTimestamp":1733611947,"startTime":"0","endTime":"0","summary":"发行人控股股东、实际控制人截至本招股说明书签署日，熊慧直接持有发行人24.42%的股份，系发行人的控股股东。近日，公司收到以上人员家属通知，熊慧女士、熊钧先生因涉嫌诈骗罪已被批捕，并移交检察机关，相关事项尚待进一步调查。目前，公司业务正常开展，经营活动正常进行。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241208065321ab65f744&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241208065321ab65f744&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688217"],"gpt_icon":0},{"id":"2489845012","title":"“肿瘤检测龙头”实控人姐弟被捕！睿昂基因被曝涉阿斯利康“骗保”案","url":"https://stock-news.laohu8.com/highlight/detail?id=2489845012","media":"市场资讯","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489845012?lang=zh_cn&edition=full","pubTime":"2024-12-06 20:18","pubTimestamp":1733487480,"startTime":"0","endTime":"0","summary":"　　因涉嫌诈骗被刑拘的“肿瘤检测龙头”4名高管“状态更新”。　　7月被指定居住监视，10月被刑事拘留。12月5日，睿昂基因公告实控人姐弟——熊慧、熊钧，因涉嫌诈骗罪被已被批捕。　　据“界面新闻”报道，睿昂基因4高管所涉案件，与阿斯利康骗保案有关。　　截至12月6日收盘，睿昂基因股价报21元/股，下跌3.36%，总市值12亿元。　　睿昂基因并未披露4名高管涉案详情。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/s/2024-12-06/doc-incypsye5396810.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU2417539215.USD","AZN","LU0889565916.HKD","LU1829250122.USD","BK4007","LU0109394709.USD","LU2236285917.USD","BK4588","BK4568","LU2456880835.USD","BK0239","LU2462157665.USD","688217","BK4585","LU0320765992.SGD"],"gpt_icon":0},{"id":"2489840257","title":"睿昂基因实控人姐弟因涉嫌诈骗被正式批捕 甬金股份实控人涉内幕交易等拟被罚没近640万","url":"https://stock-news.laohu8.com/highlight/detail?id=2489840257","media":"市场资讯","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489840257?lang=zh_cn&edition=full","pubTime":"2024-12-06 18:09","pubTimestamp":1733479740,"startTime":"0","endTime":"0","summary":"　　高德红外已向湖北省高级人民法院提起民事诉讼，控告浙江珏芯微电子有限公司及其创始人毛剑宏和六名前员工侵害其商业秘密。高德红外请求法院判令赔偿损失并销毁相关产品及设备。　　睿昂基因的实际控制人熊慧和熊钧因涉嫌诈骗被正式批捕，相关调查仍在进行中。此前，二人及其他高管因非法经营罪被拘留，现已转为诈骗罪。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-12-06/doc-incypnsm1964999.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","603995","BK0212","688217"],"gpt_icon":0},{"id":"2489424976","title":"睿昂基因跌5% 主营下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2489424976","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489424976?lang=zh_cn&edition=full","pubTime":"2024-12-06 09:46","pubTimestamp":1733449608,"startTime":"0","endTime":"0","summary":"12月06日，睿昂基因股价大幅下跌，截至09点46分，睿昂基因下跌5.02%，报20.64元/股，成交1679万元，换手率1.41%。资金动向截止发稿，睿昂基因获得主力净流入230万元，其中超大单流入366万元，大单流出136万元。融资融券方面，睿昂基因12月04日获得融资净买入187万元，当日该股融资余额为6563万元，当较前一日增加2.94%。最新财报显示，今年三季报，睿昂基因实现营业收入1.90亿元，同比减少4.62%，净利润为572.73万元，同比减少69.58%，基本每股收益为0.10元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206094655971bfd8c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206094655971bfd8c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688217"],"gpt_icon":0},{"id":"2489249064","title":"睿昂基因董事会、监事会延期换届选举","url":"https://stock-news.laohu8.com/highlight/detail?id=2489249064","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489249064?lang=zh_cn&edition=full","pubTime":"2024-12-06 09:18","pubTimestamp":1733447897,"startTime":"0","endTime":"0","summary":"财中社12月6日电睿昂基因（688217）发布关于董事会、监事会延期换届的提示性公告。公司第二届董事会及监事会的任期于2024年12月5日届满，但由于新一届董事会和监事会的换届工作仍在积极筹备中，决定将换届选举延期进行。在换届选举完成前，公司的现任董事会和监事会全体成员及高级管理人员将继续履行其职责和义务，确保董事会和监事会相关工作的连续性和稳定性。此次延期换届不会影响公司的正常运营。2024年前三季度，睿昂基因实现收入1.90亿元，归母净利润573万元。文章来源：财中社原标题：睿昂基因董事会、监事会延期换届选举","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206092910a1d7ce3a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206092910a1d7ce3a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688217"],"gpt_icon":0},{"id":"2489464730","title":"睿昂基因：熊钧辞去公司董事、副总经理职务","url":"https://stock-news.laohu8.com/highlight/detail?id=2489464730","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489464730?lang=zh_cn&edition=full","pubTime":"2024-12-05 22:29","pubTimestamp":1733408978,"startTime":"0","endTime":"0","summary":"每经AI快讯，睿昂基因 12月5日晚间发布公告称，董事会于近日收到公司实际控制人、董事兼副总经理熊钧先生，副总经理何俊彦先生，副总经理薛愉玮先生提交的书面辞职报告。熊钧先生因个人原因申请辞去公司董事、副总经理职务，辞职后将不再担任公司任何职务；何俊彦先生、薛愉玮先生因个人原因申请辞去公司副总经理职务，辞职后将在公司担任其他职务。截至发稿，睿昂基因市值为12亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205223012ab5ffc6d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205223012ab5ffc6d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688217","BK0239"],"gpt_icon":0},{"id":"2489452929","title":"睿昂基因(688217.SH)：实控人熊慧及熊钧因涉嫌诈骗罪已被批捕 并移交检察机关","url":"https://stock-news.laohu8.com/highlight/detail?id=2489452929","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489452929?lang=zh_cn&edition=full","pubTime":"2024-12-05 22:23","pubTimestamp":1733408636,"startTime":"0","endTime":"0","summary":"智通财经APP讯，睿昂基因(688217.SH)发布公告，前期，公司实际控制人、董事长兼总经理、核心技术人员熊慧，实际控制人、董事兼副总经理熊钧因涉嫌诈骗罪被公安机关采取刑事拘留的强制措施。近日，公司收到以上人员家属通知，熊慧、熊钧因涉嫌诈骗罪已被批捕，并移交检察机关，相关事项尚待进一步调查。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1221116.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"睿昂基因(688217.SH)：实控人熊慧及熊钧因涉嫌诈骗罪已被批捕 并移交检察机关","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","688217"],"gpt_icon":0},{"id":"2489245735","title":"睿昂基因：实控人熊慧、熊钧因涉嫌诈骗罪已被批捕","url":"https://stock-news.laohu8.com/highlight/detail?id=2489245735","media":"新浪证券","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489245735?lang=zh_cn&edition=full","pubTime":"2024-12-05 22:23","pubTimestamp":1733408580,"startTime":"0","endTime":"0","summary":"12月5日，睿昂基因晚间公告，前期，公司实际控制人、董事长兼总经理、核心技术人员熊慧，实际控制人、董事兼副总经理熊钧因涉嫌诈骗罪被公安机关采取刑事拘留的强制措施。近日，公司收到以上人员家属通知，熊慧、熊钧因涉嫌诈骗罪已被批捕，并移交检察机关，相关事项尚待进一步调查。近日，熊钧因个人原因申请辞去公司董事、副总经理职务，辞职后将不再担任公司任何职务。目前，公司业务正常开展，经营活动正常进行。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2024-12-05/doc-incympzk9563884.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","688217"],"gpt_icon":0},{"id":"2489452503","title":"睿昂基因：实控人熊慧、熊钧因涉嫌诈骗罪已被批捕","url":"https://stock-news.laohu8.com/highlight/detail?id=2489452503","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489452503?lang=zh_cn&edition=full","pubTime":"2024-12-05 22:21","pubTimestamp":1733408461,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0239","688217"],"gpt_icon":0},{"id":"2487437805","title":"睿昂基因（688217）11月28日主力资金净卖出319.62万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2487437805","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487437805?lang=zh_cn&edition=full","pubTime":"2024-11-29 08:22","pubTimestamp":1732839772,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年11月28日收盘，睿昂基因报收于20.75元，下跌2.35%，换手率2.45%，成交量1.37万手，成交额2894.7万元。近5日资金流向一览见下表：睿昂基因融资融券信息显示，融资方面，当日融资买入144.05万元，融资偿还285.94万元，融资净偿还141.89万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112900005071.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688217"],"gpt_icon":0},{"id":"2486489852","title":"睿昂基因（688217）11月26日主力资金净卖出504.16万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486489852","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486489852?lang=zh_cn&edition=full","pubTime":"2024-11-27 08:22","pubTimestamp":1732666962,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年11月26日收盘，睿昂基因报收于21.07元，下跌3.79%，换手率3.22%，成交量1.8万手，成交额3864.72万元。近5日资金流向一览见下表：睿昂基因融资融券信息显示，融资方面，当日融资买入447.18万元，融资偿还400.95万元，融资净买入46.23万元，连续3日净买入累计132.44万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112700007616.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688217"],"gpt_icon":0},{"id":"2486371773","title":"睿昂基因涨5% 医改政策利好","url":"https://stock-news.laohu8.com/highlight/detail?id=2486371773","media":"智选洞察","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486371773?lang=zh_cn&edition=full","pubTime":"2024-11-25 14:47","pubTimestamp":1732517233,"startTime":"0","endTime":"0","summary":"11月25日，睿昂基因股价大幅上涨，截至14点47分，睿昂基因上涨5.04%，报21.89元/股，成交3689万元，换手率3.10%。资金动向融资融券方面，睿昂基因11月22日获得融资净买入35万元，当日该股融资余额为5663万元，当较前一日增加0.64%，实现2连增。最新财报显示，今年三季报，睿昂基因实现营业收入1.90亿元，同比减少4.62%，净利润为572.73万元，同比减少69.58%，基本每股收益为0.10元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125144751a2539d95&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125144751a2539d95&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688217"],"gpt_icon":0},{"id":"2486906077","title":"睿昂基因新注册《淋巴瘤基因全景筛查分析软件V1.0》等5个项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2486906077","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486906077?lang=zh_cn&edition=full","pubTime":"2024-11-25 01:07","pubTimestamp":1732468035,"startTime":"0","endTime":"0","summary":"证券之星消息，近日睿昂基因（688217）新注册了5个项目的软件著作权，包括《淋巴瘤基因全景筛查分析软件V1.0》、《淋巴瘤全转录组测序分析软件V1.0》、《MSI统计分析软件V1.0》、《酶活检测分析软件V1.0》、《髓系血液肿瘤热点基因标准检测分析软件V1.0》等。今年以来睿昂基因新注册软件著作权7个。结合公司2024年中报财务数据，今年上半年公司在研发方面投入了3420.12万元，同比增9.17%。数据来源：企查查以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112500000228.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688217","BK0239"],"gpt_icon":0},{"id":"2485856367","title":"睿昂基因新注册《慢性淋巴细胞白血病FISH分析软件V1.0》等2个项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2485856367","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485856367?lang=zh_cn&edition=full","pubTime":"2024-11-24 01:11","pubTimestamp":1732381877,"startTime":"0","endTime":"0","summary":"证券之星消息，近日睿昂基因（688217）新注册了2个项目的软件著作权，包括《慢性淋巴细胞白血病FISH分析软件V1.0》、《弥漫大B细胞淋巴瘤（DLBCL）分子分型分析软件V1.0》等。今年以来睿昂基因新注册软件著作权2个。结合公司2024年中报财务数据，今年上半年公司在研发方面投入了3420.12万元，同比增9.17%。数据来源：企查查以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112400000119.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688217","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2021-05-17","address":"上海市奉贤区金海公路6055号3幢","stockEarnings":[{"period":"1week","weight":0.1212},{"period":"1month","weight":0.1912},{"period":"3month","weight":0.7055},{"period":"6month","weight":0.1521},{"period":"1year","weight":-0.3445},{"period":"ytd","weight":-0.3331}],"companyName":"上海睿昂基因科技股份有限公司","boardCode":"AI0027","perCapita":"11991股","boardName":"医药制造业","registeredCapital":"5585万元","compareEarnings":[{"period":"1week","weight":-0.0146},{"period":"1month","weight":0.0176},{"period":"3month","weight":0.2362},{"period":"6month","weight":0.1281},{"period":"1year","weight":0.1534},{"period":"ytd","weight":0.1369}],"survey":"　　上海睿昂基因科技股份有限公司的主营业务是体外诊断产品的研发、生产、销售及科研服务；公司的主要产品是分子诊断试剂。佰睿达是国内获批上市的白血病检测试剂盒中覆盖融合基因种类最多产品。公司也凭借该产品继续强势领跑国内白血病分子诊断行业。公司先后获得了“上海市专精特新企业”、“奉贤区科技小巨人企业”等荣誉称号，并多次承担由国家科技部、上海市科学技术委员会、上海张江高新技术产业开发区管理委员会等部门主导的多个重大科研项目。","serverTime":1734606414118,"listedPrice":18.42,"stockholders":"4658人(较上一季度增加15.96%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"睿昂基因(688217)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供睿昂基因(688217)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"睿昂基因,688217,睿昂基因股票,睿昂基因股票老虎,睿昂基因股票老虎国际,睿昂基因行情,睿昂基因股票行情,睿昂基因股价,睿昂基因股市,睿昂基因股票价格,睿昂基因股票交易,睿昂基因股票购买,睿昂基因股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"睿昂基因(688217)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供睿昂基因(688217)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}